• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低密度脂蛋白介导的二十二碳六烯酸递送可选择性杀死小鼠肝癌细胞。

Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells.

作者信息

Reynolds Lacy, Mulik Rohit S, Wen Xiaodong, Dilip Archana, Corbin Ian R

机构信息

Advanced Imaging Research Center, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.

出版信息

Nanomedicine (Lond). 2014 Jul;9(14):2123-41. doi: 10.2217/nnm.13.187. Epub 2014 Jan 7.

DOI:10.2217/nnm.13.187
PMID:24397600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4156561/
Abstract

AIM

The natural omega-3 polyunsaturated fatty acid, docosahexaenoic acid (DHA), has recently been credited for possessing anticancer properties. Herein, we investigate the cytotoxic actions of DHA-loaded low-density lipoprotein (LDL) nanoparticles in normal and liver cancer cells.

MATERIALS & METHODS: LDL-DHA nanoparticles were prepared and subjected to extensive biophysical characterization. The therapeutic utility of LDL-DHA nanoparticles was evaluated in normal and malignant murine hepatocyte cell lines, TIB-73 and TIB-75, respectively.

RESULTS & DISCUSSION: The engineered LDL-DHA nanoparticles possessed enhanced physical and oxidative stabilities over native LDL and free DHA. Dose-response studies showed that therapeutic doses of LDL-DHA nanoparticles that completely killed TIB-75 were innocuous to TIB-73. The selective induction of lipid peroxidation and reactive oxygen species in the cancer cells was shown to play a central role in LDL-DHA nanoparticle-mediated cytotoxicity.

CONCLUSION

In summary, these findings indicate that LDL-DHA nanoparticles show great promise as a selective anticancer agent against hepatocellular carcinoma.

摘要

目的

天然ω-3多不饱和脂肪酸二十二碳六烯酸(DHA)最近被认为具有抗癌特性。在此,我们研究了负载DHA的低密度脂蛋白(LDL)纳米颗粒在正常细胞和肝癌细胞中的细胞毒性作用。

材料与方法

制备了LDL-DHA纳米颗粒并进行了广泛的生物物理表征。分别在正常和恶性小鼠肝细胞系TIB-73和TIB-75中评估了LDL-DHA纳米颗粒的治疗效用。

结果与讨论

工程化的LDL-DHA纳米颗粒比天然LDL和游离DHA具有更高的物理稳定性和氧化稳定性。剂量反应研究表明,能完全杀死TIB-75的治疗剂量的LDL-DHA纳米颗粒对TIB-73无害。癌细胞中脂质过氧化和活性氧的选择性诱导在LDL-DHA纳米颗粒介导的细胞毒性中起核心作用。

结论

总之,这些发现表明LDL-DHA纳米颗粒作为一种针对肝细胞癌的选择性抗癌剂具有巨大潜力。

相似文献

1
Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells.低密度脂蛋白介导的二十二碳六烯酸递送可选择性杀死小鼠肝癌细胞。
Nanomedicine (Lond). 2014 Jul;9(14):2123-41. doi: 10.2217/nnm.13.187. Epub 2014 Jan 7.
2
Investigation into the distinct subcellular effects of docosahexaenoic acid loaded low-density lipoprotein nanoparticles in normal and malignant murine liver cells.二十二碳六烯酸负载的低密度脂蛋白纳米颗粒在正常和恶性小鼠肝细胞中的不同亚细胞效应研究。
Biochim Biophys Acta. 2016 Nov;1860(11 Pt A):2363-2376. doi: 10.1016/j.bbagen.2016.07.004. Epub 2016 Jul 11.
3
Hepatic Arterial Infusion of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles Selectively Disrupts Redox Balance in Hepatoma Cells and Reduces Growth of Orthotopic Liver Tumors in Rats.肝动脉输注低密度脂蛋白二十二碳六烯酸纳米颗粒可选择性破坏肝癌细胞中的氧化还原平衡并减少大鼠原位肝肿瘤的生长。
Gastroenterology. 2016 Feb;150(2):488-98. doi: 10.1053/j.gastro.2015.10.008. Epub 2015 Oct 17.
4
Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma.载脂蛋白 B100 二十二碳六烯酸纳米颗粒诱导肝癌细胞发生铁死亡。
Free Radic Biol Med. 2017 Nov;112:597-607. doi: 10.1016/j.freeradbiomed.2017.09.002. Epub 2017 Sep 8.
5
Effects of low-density lipoprotein docosahexaenoic acid nanoparticles on cancer stem cells isolated from human hepatoma cell lines.低密度脂蛋白二十二碳六烯酸纳米颗粒对从人肝癌细胞系分离出的癌症干细胞的影响。
Mol Biol Rep. 2018 Oct;45(5):1023-1036. doi: 10.1007/s11033-018-4252-2. Epub 2018 Aug 1.
6
Assessing the safety of transarterial locoregional delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat liver.评估载脂蛋白 E 缺陷型大鼠低密度脂蛋白二十二碳六烯酸纳米粒经肝动脉区域性给药的安全性。
Eur J Pharm Biopharm. 2021 Jan;158:273-283. doi: 10.1016/j.ejpb.2020.10.018. Epub 2020 Nov 24.
7
An implanted port-catheter system for repeated hepatic arterial infusion of low-density lipoprotein-docosahexaenoic acid nanoparticles in normal rats: A safety study.一种用于正常大鼠重复肝动脉输注低密度脂蛋白-二十二碳六烯酸纳米颗粒的植入式端口-导管系统:安全性研究。
Toxicol Appl Pharmacol. 2020 Aug 1;400:115037. doi: 10.1016/j.taap.2020.115037. Epub 2020 May 15.
8
Elucidating the structural organization of a novel low-density lipoprotein nanoparticle reconstituted with docosahexaenoic acid.阐明用二十二碳六烯酸重构的新型低密度脂蛋白纳米颗粒的结构组织。
Chem Phys Lipids. 2017 Apr;204:65-75. doi: 10.1016/j.chemphyslip.2017.03.007. Epub 2017 Mar 22.
9
Localized delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat brain using focused ultrasound.使用聚焦超声将低密度脂蛋白二十二碳六烯酸纳米颗粒局部递送至大鼠大脑。
Biomaterials. 2016 Mar;83:257-68. doi: 10.1016/j.biomaterials.2016.01.021. Epub 2016 Jan 6.
10
Influence of three rapeseed oil-rich diets, fortified with alpha-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on the composition and oxidizability of low-density lipoproteins: results of a controlled study in healthy volunteers.富含α-亚麻酸、二十碳五烯酸或二十二碳六烯酸的三种菜籽油强化饮食对低密度脂蛋白组成和氧化能力的影响:一项针对健康志愿者的对照研究结果
Eur J Clin Nutr. 2007 Mar;61(3):314-25. doi: 10.1038/sj.ejcn.1602523. Epub 2006 Sep 13.

引用本文的文献

1
APT imaging of hepatocellular carcinoma signals an effective therapeutic response in advance of tumor shrinkage.肝细胞癌的APT成像在肿瘤缩小之前就预示着有效的治疗反应。
Hepat Oncol. 2024 Dec 31;11(1):2389031. doi: 10.1080/20450923.2024.2389031. Epub 2024 Sep 12.
2
Cell Membrane Fatty Acids and PIPs Modulate the Etiology of Pancreatic Cancer by Regulating AKT.细胞膜脂肪酸和磷脂酰肌醇通过调节AKT来调控胰腺癌的病因。
Nutrients. 2024 Dec 31;17(1):150. doi: 10.3390/nu17010150.
3
Nano-Formulations of Natural Antioxidants for the Treatment of Liver Cancer.天然抗氧化剂的纳米制剂治疗肝癌。
Biomolecules. 2024 Aug 19;14(8):1031. doi: 10.3390/biom14081031.
4
Docosahexaenoic acid-loaded nanoparticles: A state-of-the-art of preparation methods, characterization, functionality, and therapeutic applications.载二十二碳六烯酸纳米颗粒:制备方法、表征、功能及治疗应用的最新进展
Heliyon. 2024 May 9;10(9):e30946. doi: 10.1016/j.heliyon.2024.e30946. eCollection 2024 May 15.
5
Low-density lipoprotein: a versatile nanoscale platform for targeted delivery.低密度脂蛋白:用于靶向递送的多功能纳米级平台。
Nanoscale Adv. 2023 Jan 24;5(4):1011-1022. doi: 10.1039/d2na00883a. eCollection 2023 Feb 14.
6
Iron as a therapeutic target in chronic liver disease.铁作为慢性肝病的治疗靶点。
World J Gastroenterol. 2023 Jan 28;29(4):616-655. doi: 10.3748/wjg.v29.i4.616.
7
Recent Development of LDL-Based Nanoparticles for Cancer Therapy.基于低密度脂蛋白的纳米颗粒用于癌症治疗的最新进展。
Pharmaceuticals (Basel). 2022 Dec 23;16(1):18. doi: 10.3390/ph16010018.
8
Repeated trans-arterial treatments of LDL-DHA nanoparticles induce multiple pathways of tumor cell death in hepatocellular carcinoma bearing rats.对携带肝癌的大鼠反复进行经动脉注射低密度脂蛋白-二十二碳六烯酸纳米颗粒治疗可诱导肿瘤细胞发生多种死亡途径。
Front Oncol. 2022 Nov 24;12:1052221. doi: 10.3389/fonc.2022.1052221. eCollection 2022.
9
Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition.载脂蛋白与脂质体的串扰作为将 5-氟尿嘧啶靶向递送至肝细胞的范例:细胞毒性和肝脏沉积。
Bioengineered. 2021 Dec;12(1):914-926. doi: 10.1080/21655979.2021.1896202.
10
Low-density lipoprotein nanomedicines: mechanisms of targeting, biology, and theranostic potential.低密度脂蛋白纳米药物:靶向机制、生物学和治疗诊断潜力。
Drug Deliv. 2021 Dec;28(1):408-421. doi: 10.1080/10717544.2021.1886199.

本文引用的文献

1
Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers.基于叶酸受体靶向的高密度脂蛋白纳米载体的近红外荧光成像用于转移性卵巢癌。
Nanomedicine (Lond). 2013 Jun;8(6):875-90. doi: 10.2217/nnm.12.137. Epub 2012 Oct 15.
2
Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma.摄入 n-3 脂肪酸和鱼类可降低肝细胞癌的风险。
Gastroenterology. 2012 Jun;142(7):1468-75. doi: 10.1053/j.gastro.2012.02.018. Epub 2012 Feb 16.
3
LRP6 protein regulates low density lipoprotein (LDL) receptor-mediated LDL uptake.LRP6 蛋白调节 LDL 受体介导的 LDL 摄取。
J Biol Chem. 2012 Jan 6;287(2):1335-44. doi: 10.1074/jbc.M111.295287. Epub 2011 Nov 28.
4
Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways.肝细胞生长因子上调通过 Akt 和 COX-2 通路促进肝癌的发生发展和上皮间质转化。
Clin Exp Metastasis. 2011 Dec;28(8):721-31. doi: 10.1007/s10585-011-9404-x. Epub 2011 Jul 10.
5
Lipoprotein-inspired nanoparticles for cancer theranostics.载脂蛋白模拟纳米颗粒用于癌症诊治一体。
Acc Chem Res. 2011 Oct 18;44(10):1105-13. doi: 10.1021/ar200017e. Epub 2011 May 10.
6
Evaluation of bacteriochlorophyll-reconstituted low-density lipoprotein nanoparticles for photodynamic therapy efficacy in vivo.评价细菌叶绿素重建的低密度脂蛋白纳米颗粒在体内光动力治疗中的疗效。
Nanomedicine (Lond). 2011 Apr;6(3):475-87. doi: 10.2217/nnm.11.8.
7
Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles.使用重组高密度脂蛋白纳米颗粒靶向递送小干扰 RNA。
Neoplasia. 2011 Apr;13(4):309-19. doi: 10.1593/neo.101372.
8
Intake of n-3 and n-6 polyunsaturated fatty acids and development of colorectal cancer by subsite: Japan Public Health Center-based prospective study.摄入 n-3 和 n-6 多不饱和脂肪酸与结直肠肿瘤亚部位发生的关系:日本基于公共卫生中心的前瞻性研究。
Int J Cancer. 2011 Oct 1;129(7):1718-29. doi: 10.1002/ijc.25802. Epub 2011 Apr 1.
9
Albumin modulates docosahexaenoic acid-induced cytotoxicity in human hepatocellular carcinoma cell lines.白蛋白调节二十二碳六烯酸诱导的人肝癌细胞系的细胞毒性。
Toxicol Lett. 2011 Feb 5;200(3):154-61. doi: 10.1016/j.toxlet.2010.11.009. Epub 2010 Nov 23.
10
Uptake of synthetic Low Density Lipoprotein by leukemic stem cells--a potential stem cell targeted drug delivery strategy.白血病干细胞摄取合成的低密度脂蛋白——一种潜在的干细胞靶向药物传递策略。
J Control Release. 2010 Dec 20;148(3):380-7. doi: 10.1016/j.jconrel.2010.09.016. Epub 2010 Sep 22.